BiomX Inc. (PHGE) Dividend History

Company News

• BiomX to Host First Quarter 2025 Financial Results Conference Call and Webcast on May 15, 2025

  BiomX, a clinical-stage company, announced that it will host a conference call to report its first quarter 2025 financial results and provide business updates.

  GlobeNewswire Inc.
• Phage Therapies Clinical Trial Pipeline Shows Potential with Active Contributions from 20+ Key Companies | DelveInsight

  The phage therapy market is experiencing significant growth due to the increasing prevalence of antibiotic-resistant infections and the growing interest in alternative treatments. Advances in biotechnology and ongoing research are driving innovation in phage-based therapeutics, offering a promising solution to combat multidrug-resistant pathogens.

  GlobeNewswire Inc.

  Featured Companies: ARMP
• BitMart Research: BMX 2024 Annual Report

  BMX, the platform token of BitMart exchange, experienced a 57.9% price increase and 56.8% market cap growth in 2024, reaching a total market capitalization of $262 million. BitMart fulfilled its commitment to repurchase BMX tokens, and the platform introduced new features like staking, small asset conversion, and stake-to-list, further enhancing its use cases.

  GlobeNewswire Inc.
• BiomX Announces a Mandatory Unit Separation

  BiomX Inc. (NYSE American: PHGE) announced a mandatory separation of its units, which trade under the ticker symbol 'PHGE.U'. The separation will occur on or about October 25, 2024, and Unit holders will receive the underlying shares of Common Stock and Warrants.

  GlobeNewswire Inc.
• UPDATE ON UNITS - BiomX Inc. Announces 1-for-10 Reverse Stock Split

  BiomX Inc. (NYSE American: PHGE) announced a 1-for-10 reverse stock split of its common stock, which will be effective on August 26, 2024. The reverse split will not change the par value or authorized shares, but will reduce the outstanding shares from approximately 178.9 million to 17.9 million.

  GlobeNewswire Inc.